isopentenyladenosine has been researched along with Hutchinson Gilford Progeria Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bifulco, M; Caruso, MG; D'Alessandro, A; Laezza, C; Malfitano, AM; Notarnicola, M; Paladino, S | 1 |
1 other study(ies) available for isopentenyladenosine and Hutchinson Gilford Progeria Syndrome
Article | Year |
---|---|
N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A.
Topics: Adolescent; Adult; Blotting, Western; Cell Nucleus; Cells, Cultured; Child; Fibroblasts; Geranyltranstransferase; Humans; Immunoprecipitation; Isopentenyladenosine; Lamin Type A; Male; Microscopy, Fluorescence; Nuclear Proteins; Plant Growth Regulators; Progeria; Protein Precursors; Protein Prenylation; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2013 |